111 Capital Makes New $793,000 Investment in Verisk Analytics, Inc. $VRSK

111 Capital acquired a new position in Verisk Analytics, Inc. (NASDAQ:VRSK) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 2,545 shares of the business services provider’s stock, valued at approximately $793,000.

Several other hedge funds and other institutional investors have also bought and sold shares of the business. Louisbourg Investments Inc. bought a new position in Verisk Analytics in the 1st quarter valued at about $25,000. Wayfinding Financial LLC bought a new position in Verisk Analytics in the 1st quarter valued at about $48,000. Ameritas Advisory Services LLC bought a new position in Verisk Analytics in the 2nd quarter valued at about $48,000. GW&K Investment Management LLC increased its holdings in Verisk Analytics by 186.7% in the 1st quarter. GW&K Investment Management LLC now owns 172 shares of the business services provider’s stock valued at $51,000 after buying an additional 112 shares during the period. Finally, Zions Bancorporation National Association UT bought a new position in Verisk Analytics in the 1st quarter valued at about $52,000. Institutional investors and hedge funds own 90.00% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have commented on the stock. Wells Fargo & Company decreased their target price on shares of Verisk Analytics from $340.00 to $334.00 and set an “overweight” rating on the stock in a report on Wednesday, September 17th. UBS Group decreased their target price on shares of Verisk Analytics from $320.00 to $300.00 and set a “neutral” rating on the stock in a report on Thursday, July 31st. Seaport Res Ptn raised shares of Verisk Analytics to a “strong-buy” rating in a report on Wednesday. Morgan Stanley raised their target price on shares of Verisk Analytics from $317.00 to $319.00 and gave the company an “equal weight” rating in a report on Thursday, July 31st. Finally, Raymond James Financial set a $315.00 price target on shares of Verisk Analytics and gave the company an “outperform” rating in a report on Monday, August 4th. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $311.00.

Insider Activity at Verisk Analytics

In related news, Director Christopher John Perry bought 1,000 shares of the business’s stock in a transaction that occurred on Wednesday, August 13th. The shares were acquired at an average cost of $259.80 per share, with a total value of $259,800.00. Following the completion of the purchase, the director directly owned 1,773 shares in the company, valued at $460,625.40. The trade was a 129.37% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Nicholas Daffan sold 5,420 shares of the stock in a transaction on Wednesday, September 3rd. The stock was sold at an average price of $265.00, for a total transaction of $1,436,300.00. Following the transaction, the insider directly owned 54,337 shares in the company, valued at approximately $14,399,305. This represents a 9.07% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 8,520 shares of company stock valued at $2,273,891 in the last ninety days. Insiders own 0.46% of the company’s stock.

Verisk Analytics Stock Up 0.7%

Shares of NASDAQ VRSK opened at $249.04 on Friday. The company has a market capitalization of $34.79 billion, a P/E ratio of 38.37, a price-to-earnings-growth ratio of 3.53 and a beta of 0.85. Verisk Analytics, Inc. has a 52-week low of $239.83 and a 52-week high of $322.92. The company has a debt-to-equity ratio of 10.34, a quick ratio of 1.53 and a current ratio of 1.53. The company’s 50 day moving average price is $262.88 and its 200-day moving average price is $288.12.

Verisk Analytics (NASDAQ:VRSK) last issued its quarterly earnings results on Wednesday, July 30th. The business services provider reported $1.88 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.77 by $0.11. The firm had revenue of $772.60 million for the quarter, compared to the consensus estimate of $767.91 million. Verisk Analytics had a net margin of 30.67% and a return on equity of 460.89%. The company’s revenue for the quarter was up 7.8% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.74 EPS. Verisk Analytics has set its FY 2025 guidance at 6.800-7.000 EPS. Equities analysts forecast that Verisk Analytics, Inc. will post 6.63 earnings per share for the current year.

Verisk Analytics Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 30th. Investors of record on Monday, September 15th were paid a dividend of $0.45 per share. The ex-dividend date of this dividend was Monday, September 15th. This represents a $1.80 annualized dividend and a yield of 0.7%. Verisk Analytics’s dividend payout ratio is currently 27.73%.

Verisk Analytics Company Profile

Verisk Analytics, Inc provides data analytics and technology solutions to the insurance markets in the United States and internationally. It offers policy language, prospective loss costs, policy writing and rating rules, and various underwriting solutions for risk selection and segmentation, pricing, and workflow optimization; property- and auto- specific rating and underwriting information solutions that allows clients to understand, quantify, underwrite, mitigate, and avoid potential loss for risks; catastrophe modeling solutions, which enables companies to identify, quantify, and plan for the financial consequences of catastrophes for use by insurers, reinsurers, intermediaries, financial institutions, and governments.